Category: Personal Injury
FDA Holds Hearings On Transvaginal Mesh
|
|
Last Modified
on
May 02, 2024
The FDA met last week to determine whether surgical mesh inserted surgically inserted into the vagina, also known as transvaginal mesh or pelvic mesh, needs tighter regulation by the FDA. The mesh is used to treat a painful condition called pelvic-organ prolapse. As the result of close to 3000 reports of adverse events, including seven… read more
New Mexico Medical Devices – Studies Link Pain Pumps To Cartilage Deterioration
|
|
Last Modified
on
May 02, 2024
On January 22, an Oregon jury awarded a chondrolysis patient nearly $5.5 million in compensation. According to New York Times, more than 150 such lawsuits are currently making their way through the court system. Chondrolysis is a rare ailment in which joint cartilage dies, resulting in bone grinding on bone. Many times this surgery affects… read more
Senate To Begin Investigation Of DePuy Hip Safety
|
|
Last Modified
on
May 02, 2024
This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA’s role in “protecting patient safety as part of the medical device approval process.” The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement… read more
Product Liability Claims Arising Out Of DePuy Hip Replacements
|
|
Last Modified
on
May 02, 2024
As reported in the Wall Street Journal – as the result of a loophole in the Food and Drug Administration’s regulation of medical implants – many potentially faulty hip implants are on the market. New drugs must undergo clinical trials before receiving FDA approval, however, if a medical implant resembles a product already on the… read more
Senator Questions Company’s Response To Paid Consultant’s Complaints About Zimmer Durom Cup
|
|
Last Modified
on
May 02, 2024
In a letter, previously posted on the WSJ website, to Zimmer CEO David Dvorak, Senator Charles Grassley raised questions regarding how the company responds to criticisms concerning joint replacement products, including the Zimmer Durom Cup (also known as the Zimmer Durom Acetabular Cup), by physicians who are paid company consultants. Grassley has a history of… read more
New Mexico Medical Device Law – Passing The MDSA Is Crucial To Patient Safety
|
|
Last Modified
on
May 02, 2024
The Medical Device Safety Act of 2009 (the “MDSA”) is one of this year’s top pieces of consumer rights legislation. This crucial legislation seeks to protect patients from dangerous and defective medical devices by reversing the effect of the Supreme Court’s ruling in Riegel v. Medtronic. Riegel provides blanket immunity from liability to some medical… read more
Zimmer NexGen Knee Recall Urged Due To Component Problems
|
|
Last Modified
on
May 02, 2024
Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that… read more
What Are the Dangers of Marketing Defects?
|
|
Last Modified
on
May 02, 2024
Defective products can lead to serious injuries or illnesses for consumers. Companies, manufacturers, retailers, and distributors all have a responsibility to ensure that products are safe to use and consume. However, it is possible for corporations to cause harm to consumers even if a product is not directly defective because they may have marketing defects… read more
Recalled Auto Accidents
|
|
Last Modified
on
May 02, 2024
Vehicle accidents occur in a wide variety of ways, most commonly due to the negligent actions of other drivers. However, there are times when vehicle accidents in New Mexico occur as a result of a defective vehicle or vehicle part. Do you know what to do if you are involved in an accident as a… read more
Invokana FDA Warning
|
|
Last Modified
on
May 02, 2024
The FDA safety communication issued a warning to the general public and the medical community that the agency is monitoring the side effects of SGLT2 inhibitors to determine whether changes need to be made in the prescribing protocol of the drug. The FDA wants patients to report any unusual side effects after starting the drug… read more
Knowledge Experience Compassion Service 
